Q22.5

Clinical Causes: Genetic factors: Some cases are linked to inherited genetic mutations. Developmental issues during pregnancy: Abnormal formation of the heart during fetal development can contribute to the condition. Environmental influences: Exposure to certain medications or substances during pregnancy may increase risk, although specific causes are often unknown.

Key Symptoms: Difficulty breathing, especially during physical activity or when lying down. Fatigue and weakness. Swelling in the legs, ankles, or abdomen due to fluid buildup. Heart palpitations or irregular heartbeat. Cyanosis, which causes a bluish tint to the lips, fingers, or toes. Poor growth or difficulty gaining weight in infants and children.

Diagnosis Path: Diagnosis of Ebstein's anomaly typically involves a combination of medical history review, physical examination, and imaging tests. An echocardiogram (ultrasound of the heart) is the primary tool used to visualize the tricuspid valve and assess its function. Additional tests may include electrocardiograms (ECG), chest X-rays, magnetic resonance imaging (MRI), or cardiac catheterization to evaluate the severity and impact of the condition on heart function.

Treatment Protocols: Treatment approaches depend on the severity of the defect and the symptoms presented. They may include: - Medications: To manage symptoms, such as diuretics for fluid retention, or medications to control irregular heartbeats. - Surgical procedures: In more severe cases, surgery may be necessary to repair or replace the malformed tricuspid valve, or to perform other corrective procedures to improve heart function. - Regular monitoring: Lifelong follow-up with a cardiologist experienced in congenital heart defects is essential for managing the condition over time. Lifestyle adjustments, such as avoiding strenuous activities or managing weight, may also be recommended to reduce stress on the heart.